Neoplasia/BPH

	Burden of bladder cancer in China from 1990 to 2023: temporal trends, modifiable risk factors, and implications for prevention. Int J Clin Oncol Bai Z, Wang S, Wang H, Liu Z, Hou S, Huang G, Hou Y. PMID: 42455460 [PubMed - as supplied by publisher]
	Immunotherapeutic strategies for castration-resistant prostate cancer: A systematic review of mechanisms, clinical advances and emerging approaches. Mol Biol Rep Xu Z, Xia Z, Li J, Yuan S, Zhao L, Wang X. PMID: 42455319 [PubMed - indexed for MEDLINE]
	Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative Review. AJR Am J Roentgenol Choi WP, Almaguel FG, Franquet-Elia E, Ghai S, Gorin MA, Repka M, Hicks RJ, Turkbey B, Umutlu L, Rowe SP, Behr SC. PMID: 42455032 [PubMed - as supplied by publisher]
	A comprehensive study of intratumor bacteria in clear-cell renal cell carcinoma identifies Cutibacterium acnes as a protector via suppression of macrophage M2 polarization. mSystems Li Y, Zhang D, Tan L, Xu J, Sun Y, Zhang R, Cheng Y, Li Y-x, Guo T, Jiang H, Zhai W, Feng C. PMID: 42454938 [PubMed - as supplied by publisher]
	Rigid cystoscopy versus flexible outpatient cystoscopy: the economic cost behind the epidemiological and social impact. Einstein (Sao Paulo) Peixoto GA, Salles MP, Amaro Junior E, Korkes F. PMID: 42454793 [PubMed - indexed for MEDLINE]
	Causal association and shared mechanisms between Graves' disease and prostate cancer: insights from Mendelian randomization, machine learning, and comprehensive bioinformatics. Aging Male Zuo M, Liao Y, Xu Q, Su A, Fu N, Zou C. PMID: 42454507 [PubMed - indexed for MEDLINE]
	Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial. Q J Nucl Med Mol Imaging Guglielmo P, Perrone E, Özcan PP, Mapelli P, Porreca A, Arslan E, Evangelista L. PMID: 42454474 [PubMed - indexed for MEDLINE]
	Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia. Front Immunol Fiala O, Tkadlecová M, Buchler T, Kopecký J, Tom, Vo, Sy, , Mat, Savka A, , Priester P, Králí, Spisarová M, Zemánková A, Lohynská R, Grmelová L, Obertová J, Stránský P Jr, Melichar B, Poprach A, Palacka P. PMID: 42454047 [PubMed - indexed for MEDLINE]
	Development and validation of multidimensional nomograms for predicting prostate cancer risk: a retrospective study. Front Oncol Zhang T, Li X, Zeng J, Xu M, Tie Y. PMID: 42453871 [PubMed]
	Erratum to: Bhatia RK, Grieb SM, Anakwenze C, Rendle KA, Ngwa W, Grover S. Investigating the Uptake of Hypofractionation for Breast and Prostate Cancer in Sub-Saharan Africa: A Qualitative Study of Physician and Medical Physicist Perspectives. Adv Radiat Oncol. 2024;10:101683. Adv Radiat Oncol Bhatia RK, Grieb SM, Anakwenze C, Rendle KA, Ngwa W, Grover S. PMID: 42453791 [PubMed]
	Post-IMvigor011 Era: CtDNA-Guided Postoperative Adjuvant Treatment Stratification in Muscle-Invasive Bladder Cancer. Cancer Manag Res Sui J, Chen Y, Jiang Y, He Q, Guo X. PMID: 42453701 [PubMed]
	Driving precision medicine in testicular germ cell tumors: from preclinical models to clinical applications. Ther Adv Med Oncol Tavares NT, Liu MY, Henrique R, Jerónimo C, Weiss RS, Lobo J. PMID: 42453649 [PubMed]
	Bladder Preservation Therapy in Muscle-Invasive Bladder Cancer: Current Evidence and Future Directions. J Clin Med Carriere PP, Hassanzadeh CJ. PMID: 42452561 [PubMed]
	Association Between Physical Activity and Mortality in Men with or at Risk of Prostate Cancer: A Systematic Review. Healthcare (Basel) García-Miralles N, Martínez-García I, Marcilla-Toribio I, Herreros-Solano A, Fernández-Bravo-Rodrigo J, Patiño-Cardona S, Moreno-Charco E, Ortega-Armiñana AM, Gregori-Navarro M, Pascual-Morena C. PMID: 42451008 [PubMed]
	Evaluation of a Methylated Circulating Tumour DNA Panel for Detection and Disease Stratification in Prostate Cancer. Int J Mol Sci Eriksen SV, Zedan AH, Kahns S, Osther PJS, Timm S, Hansen TF. PMID: 42450346 [PubMed - indexed for MEDLINE]
	Immunometabolic Stress and Immune Suppression in Clear-Cell Renal Cell Carcinoma: Perspectives in Therapeutic Strategy. Int J Mol Sci Nguyen TV, Hsu T. PMID: 42450288 [PubMed - indexed for MEDLINE]
	Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation. Int J Mol Sci Mir MM, Wani JI, Mir R, Alharthi MH, Ayed A, Nandi P, Patel AA, Mallick AK, Alamri MMS, O'haj M, Khalid TBA, Jehangir A, Sonpol HMA, Senbel AM. PMID: 42450223 [PubMed - indexed for MEDLINE]
	Diagnostic and Prognostic Non-Invasive Markers in Bladder Cancer. Diagnostics (Basel) Sim KC, Kim MJ, Sung DJ, Park BJ, Han NY, Han YE, Cha SH. PMID: 42449730 [PubMed]
	Histological Subtypes of Bladder Cancer: Epidemiology, Molecular Biology, and Clinical Implications. Cancers (Basel) Mora-Garijo B, Rahman S, Xu H, Chatzkel J, Grass GD, Spiess PE, Li R. PMID: 42449716 [PubMed]
	Head-to-Head Comparison of [68Ga]Ga-PSMA-11 PET Interpreted with Non-Contrast CT Versus Excretory-Phase CT Urography in Biochemical Recurrence of Prostate Cancer. Cancers (Basel) Betech-Antar V, Rosales JJ, Mínguez F, Romera M, Fuertes L, Díez-Caballero F, Miñana-López B, Martinez-Monge R, Guillen EF, Rodríguez-Fraile M. PMID: 42449713 [PubMed]

Articles 1 - 20 / 189777

Page 1 of 9489



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy